cbdMD acquires Bluebird Botanicals in all-equity asset deal
Source: SeekingAlpha
2026-01-14 09:10:55 ET
More on cbdMD
- cbdMD, Inc. (YCBD) Q4 2025 Earnings Call Transcript
- cbdMD regains compliance with NYSE American listing standards
- Seeking Alpha’s Quant Rating on cbdMD
- Historical earnings data for cbdMD
- Financial information for cbdMD
Read the full article on Seeking Alpha
For further details see:
cbdMD acquires Bluebird Botanicals in all-equity asset deal
cbdMD Inc.
NASDAQ: YCBD
YCBD Trading
5.98% G/L:
$0.7357 Last:
99,657 Volume:
$0.7605 Open:
YCBD Latest News
February 17, 2026 04:10:00 pm
cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026
February 12, 2026 05:31:00 pm
cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results
February 02, 2026 09:00:00 am
cbdMD's Herbal Oasis Expands into Louisiana with Morales Beverage Group Following Strong Texas Momentum
January 29, 2026 12:53:00 pm
cbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways
